Related Experiment Video

Updated: Sep 26, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Retinoids and malignant melanoma: a pathway of proliferation inhibition on SK MEL28 cell line

Laura Emionite1, Fabia Galmozzi, Patrizia Raffo

  • 1Department of Oncology, Biology and Genetics, University of Genoa, National Institute for Cancer Research, Genoa, Italy.

Anticancer Research
|April 12, 2003
PubMed
Abstract

Insights

Synthetic retinoids show potential in melanoma treatment. RO 41-5253 effectively inhibited melanoma cell proliferation via cell-cycle arrest, impacting retinoid receptor gene expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Retinoids modulate cancer processes like cell proliferation, differentiation, and apoptosis.
  • Synthetic retinoids are being investigated for their anti-cancer properties.

Purpose of the Study:

  • To evaluate the in vitro efficacy of synthetic retinoids in inhibiting human melanoma cell growth.
  • To compare the effects of selective retinoid receptor agonists and antagonists with all-trans retinoic acid.
  • To analyze retinoid-induced apoptosis and changes in gene expression.

Main Methods:

  • In vitro testing of synthetic retinoids (RAR-alpha, beta, gamma agonists; RAR-alpha antagonist) on human melanoma cell line SK MEL 28.
  • Assessment of apoptosis induction.
  • RT-PCR analysis of retinoid receptor and regulatory gene expression.

Main Results:

  • RAR-gamma agonist RO 44-4753 and RAR-alpha antagonist RO 41-5253 demonstrated significant antiproliferative effects.
  • Other synthetic retinoids showed limited efficacy.
  • All tested retinoids upregulated RAR-beta gene expression, with notable increases after RO 44-4753 and RO 41-5253 treatment.

Conclusions:

  • RO 41-5253 exhibited significant effects on melanoma proliferation and RARs mRNA expression.
  • The mechanism of action for RO 41-5253 involved cell-cycle arrest rather than apoptosis.
  • Selective retinoids, particularly RO 41-5253, show promise for melanoma therapy.

More Related Videos

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...